定量DWI及IVIM参数鉴别肝内胆管癌与肝细胞癌的诊断价值:系统综述与Meta分析
该系统综述与Meta分析纳入21项研究(1109个HCC病灶、838个ICC病灶),比较ADC、D、伪扩散系数及灌注分数f在鉴别HCC与ICC中的价值。ADC在两组间无显著差异,D在ICC显著高于HCC,f在ICC显著低于HCC。作者认为D优于ADC,支持将非高斯DWI技术整合于临床实践以改善肿瘤表征。
要点
- D在ICC显著高于HCC,而ADC在两者间无显著差异。
- 灌注分数f在ICC显著低于HCC。
- 作者认为D是优于ADC的鉴别生物标志物,支持整合非高斯DWI技术。
核心结论
- ADC因广泛可及仍具临床实用性,但该Meta分析确立D作为优于ADC的生物标志物用于鉴别ICC与HCC局灶性肝病灶。
研究设计与样本
- 系统综述与Meta分析,遵循预注册方案(https://osf.io/9yhrg),检索PubMed、Web of Science、Cochrane Library和Embase至2025年3月8日,纳入21项研究共1109个HCC病灶和838个ICC病灶,采用随机效应模型合并定量DWI参数(ADC、D、伪扩散系数、f),并行敏感性分析及发表偏倚检验。
诊断标准与关键数值
- HCC的ADC为1.10(95%CI 1.03-1.17),ICC为1.16(95%CI 1.06-1.25),两组差异无统计学显著(p=0.156)。
- HCC的D为0.89(95%CI 0.77-1.02),ICC为1.04(95%CI 0.93-1.16),两组差异有统计学显著(p<0.001)。
- ICC的伪扩散系数为53.3(95%CI 22.47-84.13),HCC为49.35(95%CI 23.28-75.41),两组差异无统计学显著(p=0.912)。
- ICC的f为19.21(95%CI 12.98-25.44),HCC为23.78(95%CI 14.76-32.8),ICC显著低于HCC(p=0.022)。
- 对每个参数计算了合并均数差、标准化均数差、百分比差异、敏感度、特异度及曲线下面积,但原文未报告具体数值。
临床应用与阅片要点
- 作者认为这些发现支持将非高斯DWI技术整合于临床实践以改善肿瘤表征,原文未据此给出具体阅片或报告建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study evaluates the diagnostic performance of quantitative diffusion-weighted imaging (DWI), including both conventional and intravoxel incoherent motion (IVIM)-derived parameters, in differentiating hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC).
METHOD: A systematic review and meta-analysis were conducted following a pre-registered protocol ( https://osf.io/9yhrg ). Relevant studies were identified through PubMed, Web of Science, Cochrane Library, and Embase up to March 8, 2025. Quantitative DWI parameters, including apparent diffusion coefficient (ADC), pure diffusion coefficient (D), pseudo-diffusion coefficient (pseudo-D), and perfusion fraction (f), were compared between HCC and ICC using a random-effects model. Sensitivity analysis and publication bias tests were performed.
RESULTS: Twenty-one studies encompassing 1109 HCC and 838 ICC lesions were included. Pooled ADC values did not differ significantly between HCC (1.10, 95% CI = 1.03 to 1.17) and ICC (1.16, 95% CI = 1.06 to 1.25) groups (p = 0.156). In contrast, D showed significant differentiation between HCC (0.89, 95% CI = 0.77 to 1.02) and ICC (1.04, 95% CI = 0.93 to 1.16), with p < 0.001. Moreover, the pseudo-D parameter demonstrated comparable values in ICC (53.3; 95% CI, 22.47-84.13) and HCC (49.35; 95% CI, 23.28-75.41) lesions (p = 0.912). Finally, the f parameter revealed significantly (p = 0.022) lower values for ICC (19.21, 95% CI = 12.98 to 25.44) compared to HCC (23.78, 95% CI = 14.76 to 32.8). For each parameter, we calculated pooled mean differences, standardized mean differences, percentage differences, sensitivity, specificity, and area under the curve.
CONCLUSION: While ADC retains clinical utility due to widespread availability, this meta-analysis establishes D as a superior biomarker over ADC for distinguishing ICC from HCC focal liver lesions. These findings support the integration of non-Gaussian DWI techniques in clinical practice for improved tumor characterization.
引用
- Mohammadzadeh S, Mohebbi A, Zare M, et al. Diagnostic value of quantitative DWI and IVIM parameters in differentiating intrahepatic cholangiocarcinoma and hepatocellular carcinoma: a systematic review and meta-analysis. Abdom Radiol (NY). 2025. PMID: 40844594. doi:10.1007/s00261-025-05072-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。